enGenes develops customized solutions for the cost-effective production of recombinant proteins in microbial expression systems. We combine a vast experience in cutting-edge genetic engineering with a broad expertise in bioprocess engineering to deliver best-in-class protein expression systems results. Based on a strong understanding for the requirements of the biotech industry and extensive knowledge and method portfolio, enGenes delivers improved host cell lines, plasmid expression vectors and optimized production processes to maximize bio-process efficacy.
Our customized project plans also responds to individual documentation requirements to support an easy transfer to the facilities and quality management system of our clients. enGenes was founded by internationally recognized scientists in the field of microbial-based protein expression with an extensive track-record of scientific publications, patents and a strong understanding for the requirements of the biotech industry from a long history of international cooperation.
• IP on a growth-decoupled microbial protein production system (enGenes-X-press technology, patent pending)
• IP on a microbial screenings system for the screening of high-producer clones
• IP on improved plasmid vector expression systems
• IP on antibiotic resistance-free plasmid selection for the production of recombinant proteins
If you are interested in any of these technologies do not hesitate to contact us and we will provide you with more detailed information.
For more information please contact us.